에티테마 -
introducing 3


MEDI-IoT is a BT (Bio Technology) convergence company that provides digital prevention/management/treatment solutions in the fields of eye diseases and geriatric diseases. Currently, we offer the eye disease treatment device MEDI-EYe and the DTx platform AgingLOC, which diagnoses and provides tailored treatment programs for geriatric diseases. MEDI-IoT provides optimal solutions that meet the needs of customers in the fields of eye diseases and geriatric diseases and has a differentiated approach that sets new standards for treatment. We strive to become a pioneer in the digital healthcare field through continuous research and innovation, and we are committed to improving people's quality of daily life.

timeline of history


April 2024

Participation and Innovation Award at Hong Kong InnoEx 2024

March 2024

Obtained MEDI-EYE KC Certification

February 2024

Medical Device Clinical Trial Application to MFDS

November 2023

Hongneung Innopolis H-Bridge Project

September 2023

TIPS Linked Support Overseas Marketing Project

September 2023

Gyeongnam Technopark Electronic Medicine, Digital Therapeutics Technology Commercialization Base

September 2023

Selected for TIPS (Linked Support Overseas Marketing)

August 2023

Participated in the China Changchun Northeast Asia Big Health Forum

July 2023

Secured Statistical Significance in Preclinical Trials (in vivo, in vitro; Dry Eye Syndrome, Dry Macular Degeneration, Macular Edema)

June 2023

Participated in the Finland Radical Healthcare Festival

May 2023

Selected for TIPS (Linked Support Startup Commercialization)

April 2023

Secured Investment from ScaleUp Partners

January 2023

Participated in CES 2023

September 2022

Selected for TIPS (Startup Incubating Support Project)

August 2022

Secured Investment from Hana Securities, Company X

May 2022

Secured Investment from Daewoong Pharmaceutical

August 2021

Company Name Changed (TechOnHeal -> MediIOT)

November 9, 2020

Obtained Class 1 Medical Manufacturing License

October 17, 2020

Established an Affiliated Research Institute

October 7, 2020

Company Founded